Dr. Reddy's Laboratories Limited
RDY
$12.70
-$0.21-1.63%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 3.72B | 3.60B | 3.47B | 3.37B | 3.29B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.72B | 3.60B | 3.47B | 3.37B | 3.29B |
| Cost of Revenue | 1.51B | 1.46B | 1.42B | 1.40B | 1.37B |
| Gross Profit | 2.21B | 2.13B | 2.05B | 1.98B | 1.91B |
| SG&A Expenses | 1.08B | 1.04B | 988.93M | 932.38M | 904.69M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -25.24M | -26.10M | -24.02M | -27.98M | -25.00M |
| Total Operating Expenses | 2.89B | 2.78B | 2.68B | 2.58B | 2.51B |
| Operating Income | 829.90M | 811.52M | 795.67M | 795.63M | 776.26M |
| Income Before Tax | 869.20M | 866.64M | 869.25M | 868.36M | 836.75M |
| Income Tax Expenses | 218.59M | 216.57M | 200.32M | 195.59M | 204.68M |
| Earnings from Continuing Operations | 650.61 | 650.07 | 668.92 | 672.77 | 632.07 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -9.17M | -10.29M | -- | -- | -- |
| Net Income | 641.44M | 639.78M | 668.92M | 672.77M | 632.07M |
| EBIT | 829.90M | 811.52M | 795.67M | 795.63M | 776.26M |
| EBITDA | 1.01B | 980.88M | 963.41M | 961.14M | 938.92M |
| EPS Basic | 0.77 | 0.77 | 0.80 | 0.81 | 0.76 |
| Normalized Basic EPS | 0.63 | 0.62 | 0.62 | 0.62 | 0.61 |
| EPS Diluted | 0.77 | 0.77 | 0.80 | 0.81 | 0.76 |
| Normalized Diluted EPS | 0.63 | 0.62 | 0.62 | 0.62 | 0.61 |
| Average Basic Shares Outstanding | 3.33B | 3.33B | 3.33B | 3.33B | 3.33B |
| Average Diluted Shares Outstanding | 3.34B | 3.34B | 3.34B | 3.33B | 3.33B |
| Dividend Per Share | 0.10 | 0.10 | 0.10 | 0.10 | 0.10 |
| Payout Ratio | 12.40% | 12.43% | 12.02% | 11.95% | 12.72% |
